How To Rig a Cancer Drug Trial 101, a true story

A parody on big pharma and FDA industry capture: How to Rig a Cancer Drug Trial 101, a true story.
Visit: https://www.ForbiddenTreatment.com
Here's a partial transcript:
How to rig a cancer drug trial 101. So you've discovered a new molecule that you wanna get into the lucrative cancer drug industry. Rigging a cancer drug trial to get FDA approval is easy if you are a big pharma company. The process can also be sped up for fast approval simply by shelling out another a hundred million or two for an accelerated approval voucher. If your pharma company doesn't have one of these, no problem, these vouchers can be simply purchased from another pharma company for a hundred million or more, such as when AstraZeneca paid $95 million to Sobi Pharma for one such voucher in 2018. Does your cancer drug actually extend survival of a stage four cancer patient? No. Well, that's okay. Not surprising at all with the way these drugs are rolled out like a drug mill. Not to worry your FDA approval will still be easy. We'll just set up surrogate endpoints, which are supposed to be, they're supposed to reflect in a shorter and cheaper clinical trial what would actually result in longer survival time, but they don't. The most well-known surrogate endpoint that most people are familiar with is simply shrinkage of a tumor in size. This one, however, has been removed because it was determined and not really accepted, that well, that smaller tumor size did not equate to better quality of life or extended survival.

But we've got a perfect surrogate endpoint for your new drug. It's called "progression-free survival". It conveniently sounds like an extension of survival and many doctors reading your study and your abstract will mistake it for that, but it's nothing of the sort, and it's super easy to manipulate the data in your study to extend "progression-free survival" because we will choose much younger and earlier detection cancer diagnosed patients for your study. This way we can show fewer side effects from the toxicity of your drug as younger people will have a much bigger tolerance regardless of the fact that the drug will primarily be prescribed to older people with later stages of cancer who will be more sensitive to its toxicities. But don't worry, these toxicities are super easy to hide within the statistics when our key opinion leaders will be publishing the clinical study that's written by our own ghostwriter.

Your FDA approval will be quick and easy, giving you plenty of time to charge whatever you want for your ineffective drug. And since we tied up Congress years ago, the insurance companies will be forced to pay full price earning you billions of dollars per year. After. After all, you can charge half a million dollars per year per patient for your toxic cocktail.

You can read more into the references from this video in this book called "Cancer, Incorporated" by Ralph Moss. Visit me at ForbiddenTreatment.com for more health info and thanks so much for watching this video. You can also subscribe for more videos on my Rumble channel at Rumble.com/psyoptruth, P-S-Y-O-P-T-R-U-T-H. Thanks again for watching. I'll see you next time.